Orthobiologics & Regenerative Medicine Series: Responsible Use of Orthobiologics in Sports Medicine: 2022 Update presented by Joanne Borg-Stein, MD-Webinar PowerPoint Presentation Slides

Webinar PowerPoint Presentation Slides

Pdf Summary

The AAP Webinar Series on Orthobiologics and Regenerative Medicine focused on the responsible use of orthobiologics in sports medicine. The webinar outlined the goals of the presentation, which included providing a brief summary of the current evidence-based indications for orthobiologics, discussing the mission statement of the MGB Regenerative Sports Medicine program, and outlining the next steps for the program.<br /><br />The presentation began by highlighting the growth of tissue engineering therapies and regenerative medicine, with over 7,000 clinical trials worldwide. The market for these therapies has also seen significant growth over the years. The presentation then introduced the concept of the regenerative medicine-orthobiologics bridge and the continuum of care gap that currently exists.<br /><br />The mission statement of the MGB Regenerative Sports Medicine program was presented, emphasizing the program's commitment to delivering evidence-based clinical care, education, research, and innovation in an interdisciplinary manner. The program aims to collaborate with various clinical and research teams to achieve its goals.<br /><br />The core team of the MGB Sports Regenerative Medicine workstream was introduced, consisting of ten MGB clinicians from different specialties. The team conducted an internal review of all MGB orthobiologic injection activity and summarized their findings by affiliation.<br /><br />The presentation also discussed the vision for the program, which includes offering a wide range of treatments at three hub sites and providing personalized care with a concierge-feel. The program also aims to be a leader in education, training, and academic productivity.<br /><br />The webinar also provided information on the current regenerative techniques offered at MGB Sports Medicine, including shockwave therapy, needle tenotomy, prolotherapy, platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC), and micronized fat adipose transfer (MFAT).<br /><br />The responsible use guidelines for these therapies were discussed, emphasizing the importance of a rigorous and structured approach to their implementation. The presentation also highlighted the importance of knowledge and training, informed consent, quality control, and outcome measures in the clinical implementation of regenerative medicine.<br /><br />Finally, the webinar touched on regulatory considerations and the need for providers to be cautious and truthful in their marketing of regenerative medicine interventions. The presentation concluded by emphasizing the importance of responsible use and the need to continually evaluate the safety and efficacy of these therapies.<br /><br />Overall, the webinar provided a comprehensive overview of the responsible use of orthobiologics in sports medicine, outlining the current evidence-based indications, discussing the mission and vision of the MGB Regenerative Sports Medicine program, and highlighting the necessary steps for responsible clinical implementation.

Keywords

AAP Webinar Series

Orthobiologics

Regenerative Medicine

Sports Medicine

Evidence-based Indications

MGB Regenerative Sports Medicine Program

Tissue Engineering Therapies

Continuum of Care Gap

Clinical Care

Education and Research